These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Suberoylanilide hydroxamic acid (SAHA) causes tumor growth slowdown and triggers autophagy in glioblastoma stem cells. Chiao MT; Cheng WY; Yang YC; Shen CC; Ko JL Autophagy; 2013 Oct; 9(10):1509-26. PubMed ID: 23962875 [TBL] [Abstract][Full Text] [Related]
3. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo. Yin D; Ong JM; Hu J; Desmond JC; Kawamata N; Konda BM; Black KL; Koeffler HP Clin Cancer Res; 2007 Feb; 13(3):1045-52. PubMed ID: 17289901 [TBL] [Abstract][Full Text] [Related]
4. Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells. Yang L; Guo H; Dong L; Wang L; Liu C; Wang X Oncol Rep; 2014 Sep; 32(3):1303-11. PubMed ID: 24970314 [TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells. Min A; Im SA; Kim DK; Song SH; Kim HJ; Lee KH; Kim TY; Han SW; Oh DY; Kim TY; O'Connor MJ; Bang YJ Breast Cancer Res; 2015 Mar; 17():33. PubMed ID: 25888415 [TBL] [Abstract][Full Text] [Related]
6. Cardamonin induces apoptosis by suppressing STAT3 signaling pathway in glioblastoma stem cells. Wu N; Liu J; Zhao X; Yan Z; Jiang B; Wang L; Cao S; Shi D; Lin X Tumour Biol; 2015 Dec; 36(12):9667-76. PubMed ID: 26150336 [TBL] [Abstract][Full Text] [Related]
7. Continuous intracranial administration of suberoylanilide hydroxamic acid (SAHA) inhibits tumor growth in an orthotopic glioma model. Ugur HC; Ramakrishna N; Bello L; Menon LG; Kim SK; Black PM; Carroll RS J Neurooncol; 2007 Jul; 83(3):267-75. PubMed ID: 17310267 [TBL] [Abstract][Full Text] [Related]
8. Temozolomide sensitizes stem-like cells of glioma spheres to TRAIL-induced apoptosis via upregulation of casitas B-lineage lymphoma (c-Cbl) protein. Zhitao J; Long L; Jia L; Yunchao B; Anhua W Tumour Biol; 2015 Dec; 36(12):9621-30. PubMed ID: 26142735 [TBL] [Abstract][Full Text] [Related]
9. Preclinical activity of combined HDAC and KDM1A inhibition in glioblastoma. Singh MM; Johnson B; Venkatarayan A; Flores ER; Zhang J; Su X; Barton M; Lang F; Chandra J Neuro Oncol; 2015 Nov; 17(11):1463-73. PubMed ID: 25795306 [TBL] [Abstract][Full Text] [Related]
10. The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells. Berghauser Pont LM; Kleijn A; Kloezeman JJ; van den Bossche W; Kaufmann JK; de Vrij J; Leenstra S; Dirven CM; Lamfers ML PLoS One; 2015; 10(5):e0127058. PubMed ID: 25993039 [TBL] [Abstract][Full Text] [Related]
11. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses vasculogenic mimicry and proliferation of highly aggressive pancreatic cancer PaTu8988 cells. Xu XD; Yang L; Zheng LY; Pan YY; Cao ZF; Zhang ZQ; Zhou QS; Yang B; Cao C BMC Cancer; 2014 May; 14():373. PubMed ID: 24886166 [TBL] [Abstract][Full Text] [Related]
12. Histone Deacetylase (HDAC) Inhibitor, Suberoylanilide Hydroxamic Acid (SAHA), Induces Apoptosis in Prostate Cancer Cell Lines via the Akt/FOXO3a Signaling Pathway. Shi XY; Ding W; Li TQ; Zhang YX; Zhao SC Med Sci Monit; 2017 Dec; 23():5793-5802. PubMed ID: 29211704 [TBL] [Abstract][Full Text] [Related]
13. MDM2 Degrades Deacetylated Nucleolin Through Ubiquitination to Promote Glioma Stem-Like Cell Enrichment for Chemotherapeutic Resistance. Ko CY; Lin CH; Chuang JY; Chang WC; Hsu TI Mol Neurobiol; 2018 Apr; 55(4):3211-3223. PubMed ID: 28478507 [TBL] [Abstract][Full Text] [Related]
15. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth. Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911 [TBL] [Abstract][Full Text] [Related]
16. Suberoylanilide hydroxamic Acid, a histone deacetylase inhibitor, alters multiple signaling pathways in hepatocellular carcinoma cell lines. Kunnimalaiyaan S; Sokolowski K; Gamblin TC; Kunnimalaiyaan M Am J Surg; 2017 Apr; 213(4):645-651. PubMed ID: 28007318 [TBL] [Abstract][Full Text] [Related]
17. Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells. You BR; Han BR; Park WH Oncotarget; 2017 Mar; 8(11):17726-17737. PubMed ID: 28099148 [TBL] [Abstract][Full Text] [Related]
18. Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastoma. Jiang W; Finniss S; Cazacu S; Xiang C; Brodie Z; Mikkelsen T; Poisson L; Shackelford DB; Brodie C Oncotarget; 2016 Aug; 7(35):56456-56470. PubMed ID: 27486821 [TBL] [Abstract][Full Text] [Related]
19. Proteasome inhibition with bortezomib induces cell death in GBM stem-like cells and temozolomide-resistant glioma cell lines, but stimulates GBM stem-like cells' VEGF production and angiogenesis. Bota DA; Alexandru D; Keir ST; Bigner D; Vredenburgh J; Friedman HS J Neurosurg; 2013 Dec; 119(6):1415-23. PubMed ID: 24093630 [TBL] [Abstract][Full Text] [Related]
20. Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells. Daniele S; Costa B; Zappelli E; Da Pozzo E; Sestito S; Nesi G; Campiglia P; Marinelli L; Novellino E; Rapposelli S; Martini C Sci Rep; 2015 Apr; 5():9956. PubMed ID: 25898313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]